Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

NuVasive, Inc. (NUVA)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
56.06-0.48 (-0.85%)
At close: 4:00PM EDT
56.06 0.00 (0.00%)
After hours: 05:02PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close56.54
Open55.98
Bid54.30 x 800
Ask57.79 x 3100
Day's Range55.18 - 56.37
52 Week Range43.11 - 72.61
Volume639,212
Avg. Volume644,323
Market Cap2.939B
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-0.72
Earnings DateOct 27, 2021 - Nov 01, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est73.69
  • Zacks

    NuVasive (NUVA) Announces Two Developments in Cohere TLIF Line

    According to NuVasive (NUVA), Porous PEEK is a clear differentiator for the company in the market.

  • PR Newswire

    NuVasive Launches Latest Porous PEEK Implant for Posterior Spine Surgery

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the launch of the Cohere® TLIF-O implant and upcoming launch of the Cohere TLIF-A implant planned for later in the fourth quarter. With these additions to its Advanced Materials Science™ (AMS) portfolio, NuVasive is the only company to offer both porous PEEK and porous titanium implants for posterior spine su

  • PR Newswire

    NuVasive Announces First Commercial Cases Utilizing the Pulse Platform

    NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced Drs. Michael Kachmann and Zachary Tempel from Mayfield Brain & Spine in Ohio, and Dr. Paul Holman from Houston Methodist Hospital in Texas, completed the first commercial cases with the NuVasive Pulse® platform.

Advertisement
Advertisement